Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
In today's Pharmaceutical Executive Daily, Parabilis Medicines prices a record-breaking $670 million IPO, Swedish biotech AlzeCure Pharma enters a co…
1 month ago
The Ron Lanton Report: From Innovation to Infrastructure
In this episode, Ron Lanton draws on insights from the JP Morgan Healthcare Conference to explain how healthcare investment is shifting from backing …
1 month ago
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
In today's Pharmaceutical Executive Daily, a pharma funding roundup covers two RNA-focused biotechs that secured fresh capital, GSK announces a $10.6…
1 month ago
Pharmaceutical Executive Daily: Roche and Nurix Therapeutics Announce Global Collaboration
In today's Pharmaceutical Executive Daily, Roche and Nurix Therapeutics announce a global collaboration, a pharma M&A roundup covers three deals anno…
1 month ago
Pharmaceutical Executive Daily: Supreme Court Unanimously Rules in Favor of Hikma Pharmaceuticals in Skinny Label Case
In today's Pharmaceutical Executive Daily, the Supreme Court unanimously rules in favor of Hikma Pharmaceuticals in its patent dispute with Amarin ov…
1 month, 1 week ago
Pharmaceutical Executive Daily: Alnylam Pharmaceuticals and Inceptive Nucleics Announce 3 Year Strategic Collaboration
In today's Pharmaceutical Executive Daily, Eli Lilly escalates its 340B enforcement standoff by notifying covered entities of a five-business-day win…
1 month, 1 week ago
Navigating PBM Pitfalls: Protecting Revenue in a Complex Rebate Landscape
In this episode of Pricing & Policy with Model N, Jesse Mendelsohn, senior vice president at Model N, joins host Mike Christel to offer a candid, ex…
1 month, 1 week ago
Pharmaceutical Executive Daily: New FDA Draft Guidance Targets Gene Therapy Submission Burden
In today's Pharmaceutical Executive Daily, Cam Olig of Prescryptive Health touches on the results of a new market access survey, Eli Lilly and Ascidi…
1 month, 1 week ago
Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301
In today's Pharmaceutical Executive Daily, FDA has accepted a new drug application for giredestrant under priority review, FDA also issues a complete…
1 month, 1 week ago
Pharmaceutical Executive Daily: FDA Approves Xocova
In today's Pharmaceutical Executive Daily, the FDA approves Shionogi's Xocova, a pharma M&A roundup covers Servier's acquisition of Edgewise Therapeu…
1 month, 1 week ago